Previous 10 | Next 10 |
The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Cardiovascular Systems, Inc. 2021 Q1 - Results - Earnings Call Presentation
Cardiovascular Systems, Inc. (CSII) Q1 2021 Results Conference Call November 04, 2020 04:30 PM ET Company Participants Jack Nielsen - Head, IR Scott Ward - Chairman, President, and Chief Executive Officer Rhonda Robb - Operating Officer Jeff Points - Chief Financial Officer Dr. Ryan Egeland -...
Image source: The Motley Fool. Cardiovascular Systems Inc (NASDAQ: CSII) Q1 2021 Earnings Call Nov 4, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Cardiovascular Systems Inc (CSII) Q1 2021 Earnings Call Transcrip...
Cardiovascular Systems (CSII): FQ1 GAAP EPS of -$0.05 beats by $0.17.Revenue of $60.5M (-6.2% Y/Y) beats by $3.99M.FQ2 2021 guidance: Revenue of $63M-$67M vs consensus of $65.9M, representing sequential revenue growth compared to the first quarter of fiscal 2021 of 4% to 11%;Gross profit...
Conference Call Scheduled for Today, November 4, 2020, at 3:30 PM CT (4:30 PM ET) Revenues of $60.5 million increased 42% sequentially and decreased 6.1% compared to last year Net loss was $2.1 million, or $0.05 per basic and diluted share Management prov...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that results from a large retrospective observ...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that results from a large retrospective observ...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Kelvin Womack. ...
The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with their 2020 Q4 earnings Read more ...
Image source: The Motley Fool. Cardiovascular Systems Inc (NASDAQ: CSII) Q4 2020 Earnings Call Aug 4, 2020 , 4:30 p.m. ET Operator Continue reading
News, Short Squeeze, Breakout and More Instantly...
Cardiovascular Systems Inc. Company Name:
CSII Stock Symbol:
NASDAQ Market:
Cardiovascular Systems Inc. Website:
Cytek Biosciences Set to Join S&P SmallCap 600 Cytek Biosciences Set to Join S&P SmallCap 600 PR Newswire NEW YORK , April 25, 2023 /PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P S...
Largest randomized coronary atherectomy trial ever conducted Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today...
NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: INDUS Realty Trust, Inc. (NASDAQ:I...